Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
Metformin hydrochloride
Aspen Pharma Pty Ltd
Medicine Registered
FORMET ASPEN- Product Information Page 1 of 9 PRODUCT INFORMATION FORMET ASPEN 500 AND FORMET ASPEN 850 LIFE THREATENING LACTIC ACIDOSIS CAN OCCUR DUE TO ACCUMULATION OF METFORMIN. RISK FACTORS INCLUDE RENAL IMPAIRMENT, OLD AGE AND THE USE OF HIGH DOSES OF METFORMIN ABOVE 2 G PER DAY. NAME OF THE MEDICINE Metformin hydrochloride. [http://www.appco.com.au/appguide/drug.asp?drug_id=00202405] The chemical name for metformin hydrochloride is 1, 1-dimethylbiguanide hydrochloride. C 4 H 11 N 5 •HCl Molecular weight: 165.6 Cas No: 1115-70-4 DESCRIPTION Metformin hydrochloride is a white, crystalline powder which is odourless or almost odourless and hygroscopic. It is freely soluble in water, slightly soluble in ethanol (96%), and practically insoluble in chloroform and ether. FORMET ASPEN tablets are available in two strengths and contain either 500 mg or 850 mg of metformin hydrochloride. The tablets also contain the following excipients: sodium starch glycollate type A, povidone, maize starch, magnesium stearate, colloidal anhydrous silica, hypromellose, macrogol 6000, purified talc, titanium dioxide and propylene glycol. The tablets are gluten free. NH N H 2 N CH 3 CH 3 NH NH , HCl FORMET ASPEN- Product Information Page 2 of 9 PHARMACOLOGY Metformin is an oral biguanide hypoglycaemic agent. It causes an increased peripheral uptake of glucose by increasing the biological efficiency of available exogenous or endogenous insulin. The mode of action of metformin may be linked to an increase of insulin sensitivity. It does not stimulate insulin release but does require the presence of insulin to exert its hypoglycaemic effect. Possible mechanisms of action include inhibition of gluconeogenesis in the liver, delay in glucose absorption from the gastrointestinal tract and an in Olvassa el a teljes dokumentumot